# AbCellera Biologics Inc. (ABCL)

> Healthcare · CA · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ABCL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 12.37M | $ -98.59M | $ -73.35M | $ 135.62M | $ 896.02M |
| 2025 | $ 76.92M | $ -149.91M | $ -178.23M | $ 143.22M | $ 966.90M |
| 2024 | $ 30.31M | $ -171.18M | $ -195.83M | $ 65.36M | $ 1.06B |
| 2023 | $ 41.12M | $ -158.29M | $ -130.89M | $ 77.38M | $ 1.15B |
| 2022 | $ 542.27M | $ 177.08M | $ 229.43M | $ 82.26M | $ 1.23B |
| 2021 | $ 446.01M | $ 182.42M | $ 225.43M | $ 40.07M | $ 1.03B |
| 2020 | $ 297.02M | $ 151.49M | $ 10.47M | $ 6.78M | $ 830.51M |
| 2019 | $ 14.99M | $ -2.85M | $ -1.68M | $ 6.89M | $ 10.25M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.15 |
| Liabilities / Eq | 0.46 |
| Current Ratio | 12.77 |

## Other views

- [Metrics](https://sponda.capital/en/ABCL.md)
- [Charts](https://sponda.capital/en/ABCL/charts.md)
- [Compare](https://sponda.capital/en/ABCL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.